CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $342,000 | +11300.0% | 169,345 | +12490.7% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 1,345 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -25.0% | 1,345 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -83.0% | 1,345 | -79.8% | 0.00% | – |
| Q1 2021 | $47,000 | +683.3% | 6,645 | +394.1% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 1,345 | +108.5% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 645 | +37.2% | 0.00% | – |
| Q1 2020 | $3,000 | -99.4% | 470 | -99.0% | 0.00% | -100.0% |
| Q4 2019 | $504,000 | +7100.0% | 48,300 | +2741.2% | 0.00% | – |
| Q3 2019 | $7,000 | +133.3% | 1,700 | +750.0% | 0.00% | – |
| Q2 2019 | $3,000 | -40.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | -54.5% | 200 | -66.7% | 0.00% | – |
| Q4 2018 | $11,000 | +57.1% | 600 | +160.9% | 0.00% | – |
| Q3 2018 | $7,000 | -36.4% | 230 | -8.0% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | -35.0% | 250 | -16.7% | 0.00% | – |
| Q4 2017 | $20,000 | -20.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $25,000 | -10.7% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | +180.0% | 300 | +87.5% | 0.00% | – |
| Q1 2017 | $10,000 | -23.1% | 160 | -46.7% | 0.00% | – |
| Q4 2016 | $13,000 | +18.2% | 300 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -59.3% | 300 | -85.0% | 0.00% | – |
| Q2 2016 | $27,000 | +350.0% | 2,000 | +566.7% | 0.00% | – |
| Q1 2016 | $6,000 | -99.2% | 300 | -96.3% | 0.00% | -100.0% |
| Q3 2015 | $745,000 | +4.6% | 8,100 | 0.0% | 0.01% | +10.0% |
| Q2 2015 | $712,000 | +18.5% | 8,100 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $601,000 | +37.5% | 8,100 | +3.8% | 0.01% | +33.3% |
| Q4 2014 | $437,000 | +23.4% | 7,800 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $354,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |